 |
   
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
U.S. News Ranbaxy Pharmaceuticals Receives FDA Approval for Generic Version of GlaxoSmithKline's ValtrexFebruary 2, 2007 The Food and Drug Administration has approved a generic form of Valtrex (valacyclovir hydrochloride), GlaxoSmithKline's treatment for genital herpes and shingles, Indian generics maker Ranbaxy Laboratories Ltd. announced Thursday. The approved doses are for 500-mg and 1-gram caplets, the firm said. On Wednesday, Mylan Laboratories received tentative approval of its own 500-mg and 1,000-mg generic versions of Valtrex; however, the company cannot yet market its products due to outstanding patent issues. Patent issues for Mylan will resolve when patents begin to expire June 2009. Associated Press 02.01.2007  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
|
|
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
